The evolution of the ADC market – and what it means for commercial packaging - Pharmaceutical Technology

We explore the ADC market’s evolution, the unique challenges of packaging ADCs, and how strategic collaborations can help companies navigate future trends and requirements. As an innovative class of targeted cancer therapeutics, ADCs require specialized packaging solutions to protect their stability and enable safe, high-containment handling and transportation. This article explores the market’s evolution, the unique challenges of packaging ADCs, and how strategic collaborations can help companies navigate future trends and requirements. The ADC market The first antibody drug conjugate (ADC) was approved in 2000 by pairing a cytotoxic chemotherapy agent with the targeting abilities of a monoclonal antibody, and…

Miranda McLaren · 2026-06-22

We explore the ADC market’s evolution, the unique challenges of packaging ADCs, and how strategic collaborations can help companies navigate future trends and requirements.

Source: Pharmaceutical Technology